Palisade Bio (FRA:7NS0) Accounts Payable & Accrued Expense : €1.93 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Palisade Bio Accounts Payable & Accrued Expense?

Palisade Bio's quarterly accounts payable & accrued expense declined from Sep. 2023 (€1.63 Mil) to Dec. 2023 (€1.28 Mil) but then increased from Dec. 2023 (€1.28 Mil) to Mar. 2024 (€1.93 Mil).

Palisade Bio's annual accounts payable & accrued expense increased from Dec. 2021 (€1.58 Mil) to Dec. 2022 (€2.03 Mil) but then declined from Dec. 2022 (€2.03 Mil) to Dec. 2023 (€1.28 Mil).

Palisade Bio Accounts Payable & Accrued Expense Historical Data

The historical data trend for Palisade Bio's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palisade Bio Accounts Payable & Accrued Expense Chart

Palisade Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

4.34

1.58

2.03

1.28

Palisade Bio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial											0.94	1.40	1.63	1.28	1.93

Palisade Bio Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Palisade Bio (FRA:7NS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (FRA:7NS0) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

PALI:USA

Address

5800 Armada Drive, Suite 2A, Carlsbad, CA, USA, 92008

Website

https://www.palisadebio.com

Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Palisade Bio (FRA:7NS0) Headlines

No Headlines